Actively Recruiting
A Preference Study Comparing the Components of Composite Endpoints for Healthcare Providers and Patients With Coronary Artery Disease
Led by Xijing Hospital · Updated on 2026-01-30
600
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying how patients and medical staff value different components of composite endpoints often used in cardiovascular clinical trials, especially for coronary artery disease (CAD). The study aims to better understand the relative importance of events like myocardial infarction, stroke, and others compared to death, as opinions may differ between patients and healthcare providers. This observational study will help clarify how weighting these endpoints could improve trial interpretations. Participants include patients with acute or chronic coronary syndrome who have undergone percutaneous coronary intervention, as well as healthcare providers treating CAD. Both groups will complete a questionnaire that assesses how they weigh various clinical events relative to death. The study focuses on collecting and comparing these preferences to understand any differences. Participants will complete the questionnaire before hospital discharge. The study measures the relative weights assigned to myocardial infarction, stroke, cardiopulmonary resuscitation, procedural complications, major bleeding, acute kidney injury, revascularization, and rehospitalization compared to death. This observational process involves no treatment but gathers data on preferences, with total involvement lasting from enrollment until questionnaire completion before discharge.
CONDITIONS
Brief Title
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with acute or chronic coronary syndrome who have undergone percutaneous coronary intervention
- Patients who can understand the purpose of this trial and are willing to participate in the preference questionnaire
- Healthcare providers who treat patients with coronary artery disease
You will not qualify if you...
- Younger than 18 years old
- Unable to understand the questionnaire or with cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Before discharge
Participants complete a questionnaire regarding the weights given to individual components of the composite endpoint in coronary artery disease.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032
Actively Recruiting
Research Team
R
Ruining Zhang, BSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here